AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 285 filers reported holding AMEDISYS INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $254,982 | -51.9% | 2,730 | -52.9% | 0.00% | -50.0% |
| Q2 2023 | $530,352 | +442.2% | 5,800 | +336.1% | 0.00% | – |
| Q1 2023 | $97,822 | -81.2% | 1,330 | -78.6% | 0.00% | -100.0% |
| Q4 2022 | $519,118 | +180.6% | 6,214 | +225.7% | 0.00% | +200.0% |
| Q3 2022 | $185,000 | -21.6% | 1,908 | +39.5% | 0.00% | -50.0% |
| Q1 2022 | $236,000 | -57.4% | 1,368 | -60.1% | 0.00% | -66.7% |
| Q4 2021 | $554,000 | -21.8% | 3,425 | -27.9% | 0.01% | -33.3% |
| Q3 2021 | $708,000 | -20.9% | 4,749 | +30.0% | 0.01% | -30.8% |
| Q2 2021 | $895,000 | -8.1% | 3,654 | -0.7% | 0.01% | -23.5% |
| Q1 2021 | $974,000 | -12.5% | 3,679 | -3.0% | 0.02% | -19.0% |
| Q4 2020 | $1,113,000 | -39.8% | 3,793 | -51.5% | 0.02% | -46.2% |
| Q3 2020 | $1,848,000 | +1.0% | 7,817 | -28.7% | 0.04% | -53.0% |
| Q4 2019 | $1,829,000 | +19.6% | 10,958 | -6.1% | 0.08% | +144.1% |
| Q3 2019 | $1,529,000 | +7.5% | 11,672 | -0.3% | 0.03% | -2.9% |
| Q2 2019 | $1,422,000 | – | 11,712 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,588,750 | $257,187,000 | 2.54% |
| Integral Health Asset Management, LLC | 50,000 | $8,094,000 | 2.24% |
| Capital Impact Advisors, LLC | 15,094 | $2,443,000 | 1.68% |
| Advantage Alpha Capital Partners LP | 63,558 | $10,289,000 | 1.47% |
| Bridge City Capital, LLC | 19,265 | $3,119,000 | 1.29% |
| Bell Asset Management Ltd | 47,555 | $7,698,000 | 1.24% |
| Bellevue Group AG | 490,012 | $79,323,000 | 0.82% |
| Sio Capital Management, LLC | 15,000 | $2,428,000 | 0.73% |
| TILIA FIDUCIARY PARTNERS, INC. | 5,027 | $814,000 | 0.65% |
| HARBOR CAPITAL ADVISORS, INC. | 8,532 | $1,381,000 | 0.50% |